本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Karyopharm Therapeutics Inc.

8.16
+0.10001.24%
盤後8.160.00000.00%18:13 EDT
成交量:29.49萬
成交額:241.37萬
市值:1.85億
市盈率:-0.55
高:8.42
開:8.07
低:8.00
收:8.06
52周最高:10.99
52周最低:3.65
股本:2,266.29萬
流通股本:2,139.52萬
量比:0.47
換手率:1.38%
股息:- -
股息率:- -
每股收益(TTM):-14.8444
每股收益(LYR):-17.9300
淨資產收益率:-891.05%
總資產收益率:-40.62%
市淨率:-0.70
市盈率(LYR):-0.46

資料載入中...

2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/14

重要事件披露

Form 8-K - Current report
2026/05/13

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/12

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/11

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/03

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/03

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/27

重要事件披露

Form 8-K - Current report
2026/03/24

重要事件披露

Form 8-K - Current report
2026/03/03

重要事件披露

Form 8-K - Current report
2026/02/20

重要事件披露

Form 8-K - Current report
2026/02/13

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/12

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2025/11/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/03

重要事件披露

Form 8-K - Current report